Viagra

Pfizer 2014 guidance threatened by Celebrex competition

The early onset of generic competition to Celebrex comes after a torrid time for Pfizer in terms of patent losses, with cholesterol lowerer Lipitor (atorvastatin), gastrointestinal medicine Protonix (pantoprazole), Viagra (sildenafil)

Pfizer still number one - just

For Pfizer this loomed largest with the $1.6bn it lost from its Lipitor (atorvastatin) franchise last year, along with a further $1.9bn from 24 other brands, including Viagra (sildenafil)

Pfizer beats earnings estimates as new products grow

Generic competition to mature products such as erectile dysfunction therapy Viagra (sildenafil) - which fell 14 per cent to $476m - as well as the strength of the dollar took their toll on

Who tops the pharma list?

Lipitor sales fell from $9.6bn to $3.9bn, while patent expirations for Caduet (cardiovascular) and Viagra (erectile dysfunction) during the same period also had major ramifications.

Pfizer’s Paul Haley joins bmore Creative

Haley spent 12 years at pharma company Pfizer, most recently serving as primary care brand director for erectile dysfunction drug Viagra in the EU.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]